title: The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation.
authors.forename: A
authors.initials: A
authors.lastname: Anguita
authors.forename: H A
authors.initials: HA
authors.lastname: Repetto
authors.forename: L
authors.initials: L
authors.lastname: Rodriguez-Rilo
authors.forename: L A
authors.initials: LA
authors.lastname: Vazquez
authors.forename: A
authors.initials: A
authors.lastname: Iturzaeta
authors.forename: G
authors.initials: G
authors.lastname: Morrone
authors.forename: R
authors.initials: R
authors.lastname: Deheza
authors.forename: L
authors.initials: L
authors.lastname: Maldonado
authors.forename: J L
authors.initials: JL
authors.lastname: Goldberg
mesh_terms: D000293:Adolescent; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018579:Patient Selection; D012307:Risk Factors
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine